Navigation Links
Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
Date:2/3/2010

nue over the remaining period of the Company's original research collaboration with Sigma-Aldrich.

Research and development expenses were $8.7 million for the fourth quarter of 2009, compared to $6.7 million for the same period in 2008.  The increase in research and development expenses was primarily due to expenses related to the initiation of new clinical trials, including a Phase 2b clinical study of SB-509 in moderately severe diabetic neuropathy (DN) and Sangamo's ZFP Therapeutic for the treatment of recurrent glioblastoma, as well as the prosecution of clinical trials for Sangamo's ZFP Therapeutic for HIV/AIDS and increased personnel costs, including non-cash employee stock-based compensation.  

General and administrative expenses were $4.0 million for the fourth quarter of 2009, compared to $2.3 million for the same period in 2008. The increase in general and administrative expenses was primarily due to increased personnel costs, including non-cash employee stock-based compensation, and professional fees.

Total operating expenses for the fourth quarter of 2009 were $12.7 million, compared to $9.0 million for the same period in 2008.

Net interest income and other income / expense were recorded as income of $22,000 for the fourth quarter of 2009, compared to an expense of $375,000 for the same period in 2008.  The increase was due to a foreign currency translation loss during the prior year quarter.

Full Year Results

For the year ended December 31, 2009, the consolidated net loss was $18.6 million, or $0.44 per share, compared to a net los
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
2. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
4. Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
5. Sangamo Announces Pricing of Public Offering of Common Stock
6. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
7. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
8. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
9. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
10. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
11. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 02, 2014 IAL is pleased ... of its report on the markets for rigid ... examines the developments encountered in the global market ... , Full Report With TOC @ ... trends driving the demand. The study presents production ...
(Date:10/2/2014)... MO (PRWEB) October 02, 2014 Permian ... business in the St. Louis, Missouri, area on October ... has become a leading plastic injection molder in the ... machines and is a supplier to many Fortune 500 ... customer support every step of the way, from concept ...
(Date:10/2/2014)... de 2014 Laborie Medical Technologies, Inc. ("LABORIE"), ... ha completado la adquisición de Unisensor AG y Unisensor ... sede central sita en Wiesendangen, Suiza, y lleva a ... New Hampshire . Unisensor está especializada en el ... para evaluar la presión y valores de pH para ...
(Date:10/2/2014)... -- SIRO Clinpharm, an award-winning Clinical Research ... Annual Conference of the Society for Clinical Data Management ... where they were invited to speak at three sessions. ... to support fraud detection, ,clinical data management,s role in ... together as virtual and integrated teams,. The award-winning streak ...
Breaking Biology Technology:Global Overview of the Spray Polyurethane Foam (SPF) & One Component Foam (OCF) : Industry Analysis, Size, Share, Trends And Forecast Research Report by Researchmoz 2Permian Plastics LLC Celebrates 20 Years As Leading Manufacturer of Plastic Molds 2LABORIE adquiere Unisensor AG y Unisensor USA, Inc. 2SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas 2
... 15 MannKind,Corporation (Nasdaq: MNKD ), focused on ... today that it,will present at the UBS Global Life ... (ET) at the Grand Hyatt in New York., ... web cast of the,presentation in the Investor Relations section ...
... Join as Company Enters Commercialization Phase, NAPLES, ... TO ETHANOL(TM), the most advanced third generation biofuels,technology, ... with the,appointments Greg Schlicht as Senior Vice President ... as Senior Program Manager., Mr. Schlicht will ...
... Sept. 15 Insmed Inc. (Nasdaq:,INSM) a developer ... Allan, Ph.D., CEO of Insmed, will present at ... will be discussing,the Company,s perspective on the potential ... will also Chair a panel on this topic ...
Cached Biology Technology:Algenol Biofuels Further Strengthens Team With Key Appointments 2Insmed to Present at Biosimilars 2008 Conference 2
(Date:9/30/2014)... 2014--Sea monkeys have captured the popular attention of both ... life cycle -- sold as dehydrated eggs, these tiny ... more than a tank of salt water. , ... other zooplankton, brine shrimp vertically migrate in large groups ... the surface at night and retreating deeper during the ...
(Date:9/30/2014)... team of environmental scientists and engineers, led by ... a three-year, $5.25 million grant from the U.S. ... Research to make a direct positive impact on ... and disposal of radioactive contaminants. , "Understanding the ... dealing with environmental aspects of nuclear technologies is ...
(Date:9/30/2014)... can live in almost any aquatic environment on Earth, ... many species are pushed to the limit. The amount ... prove critical for how different species cope in the ... University of Gothenburg, published in the scientific journal ... change continues apace thanks to increasing levels of greenhouse ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Shape up quickly -- applies to fish, too! 2
... the Bellvitge Biomedical Research Institute (IDIBELL) at the ... into how the IDPN nitrile causes neurological syndromes ... (ALS), a severe neuromuscular degenerative disease. The study, ... in Neuropathology and Applied Neurobiology journal. ...
... to dust off the garden tables and chairs. But garden furniture ... covered with a slimy film of algae, moss, bacteria and fungi ... hoping that they can solve this problem by incorporating titanium dioxide ... adding a little bit of sunlight. When these titanium dioxide molecules ...
... German . Zebrafish share most organ systems ... the causes of human diseases like cancer or heart diseases. ... With the European Zebrafish Resource Center (EZRC), Karlsruhe Institute of ... such lines in Europe. The EZRC is funded jointly by ...
Cached Biology News:Poisoning from industrial compounds can cause similar effects to ALS 2Cleaning with sunlight 2Zebrafish -- the stars of biomedicine 2